VolitionRX Ltd. (VNRX)
AMEX · Common · CUSIP 928661107
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for VNRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
928661107
Market Cap
Small Cap
Business: VolitionRX Ltd.is a multi-national life sciences company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. Volition is primarily focused on human diagnostics but also has a majority-owned subsidiary focused on animal diagnostics. Volition's research and development activities are centered in Belgium, with additional offices in Texas, London and Singapore, as the company focuses on bringing its diagnostic products to market.

Company Contact

CEO
Cameron Reynolds
CFO
Terig Hughes
Headquarters
1489 West Warm Springs Road, Suite 110, Henderson, NV 89014
Phone
646-650-1351
Investor Relations
Scott Powell · 646-650-1351 · investorrelations@volitionrx.com
General Email
info@volitionrx.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »